Clinical Trial Update: Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of OPL-0401 in diabetic retinopathy; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• OPL-0401

Snippet

Sponsor: Valo Health, Inc. | Conditions: Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING